Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for Blue Rubber Bleb Nevus Syndrome and Venous Malformation
NCT03767660Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in Blue Rubber Bleb Nevus Syndrome (BRBNS) and venous malformation (VM), sponsored by Peking Union Medical College Hospital. Primary endpoint: Total venous malformation lesion load at 1 year. Status: unknown.
02
Drugs
sirolimus
03
Conditions
Blue Rubber Bleb Nevus Syndrome (BRBNS)venous malformation (VM)
Beyond the preview
Go deeper on NCT03767660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03767660.